Literature DB >> 1712749

Rhabdoid tumors of soft tissues: a clinicopathologic study of 26 cases enrolled on the Intergroup Rhabdomyosarcoma Study.

R Kodet1, W A Newton, N Sachs, A B Hamoudi, R B Raney, L Asmar, E A Gehan.   

Abstract

Twenty-six cases of malignant soft tissue tumors with features similar to renal rhabdoid tumors were identified among approximately 3,000 childhood sarcomas entered on Intergroup Rhabdomyosarcoma Studies I-III. The tumors consisted of polygonal cells with vesicular nuclei and prominent nucleoli and cytoplasmic intermediate filament inclusions as identified by electron microscopy and immunohistochemistry. The growth pattern was predominantly solid or solid-trabecular. Immunohistochemistry showed vimentin, wide spectrum keratin, and epithelial membrane antigen to be the most consistent antigenic phenotypes. Eleven patients were infants less than 1 year of age. The tumors affected predominantly soft tissues of proximal extremities, trunk, and retroperitoneum/pelvis/abdomen. Nineteen patients died within 1 to 82 months (median, 6 months) from the start of treatment. Five patients have survived the disease for 2 to 13 years. When compared with the survival analysis of 991 Intergroup Rhabdomyosarcoma Study II patients, it was obvious that this group of tumors fares very poorly (P less than .001). The tumor belongs to the group of soft tissue neoplasms showing mesenchymal and subtle epithelial differentiation, similar to epithelioid sarcoma. Because of its identifiable histology, site and age distribution, and poor outcome, it warrants a status as an independent entity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712749     DOI: 10.1016/0046-8177(91)90289-2

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  28 in total

Review 1.  renal tumors and tumor-like lesions in pediatric patients.

Authors:  J M Kissane; L P Dehner
Journal:  Pediatr Nephrol       Date:  1992-07       Impact factor: 3.714

2.  Cutaneous malignant rhabdoid tumor in the palm of an adult.

Authors:  Masaki Fujioka; Kenji Hayashida; Chikako Murakami; Masanori Hisaoka; Yoshinao Oda; Masahiro Ito
Journal:  Rare Tumors       Date:  2013-07-12

3.  Rhabdoid tumours of the central nervous system. Report of three cases with immunocytochemical and ultrastructural findings.

Authors:  A Cossu; G Massarelli; V Manetto; G Viale; F Tanda; L Bosincu; P Iuzzolino; S Cossu; R Padovani; V Eusebi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

4.  MRI of congenital rhabdoid tumor of the neck: case report.

Authors:  S S Roy; S K Mukherji; M Castillo; T O'Connell
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

5.  Malignant rhabdoid tumor of the small intestine in an adult: a case report with immunohistochemical and ultrastructural findings.

Authors:  Y Chen; S M Jung; T C Chao
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

6.  Rhabdoid Variant of Myoepithelial Carcinoma, with EWSR1 Rearrangement: Expanding the Spectrum of EWSR1-Rearranged Myoepithelial Tumors.

Authors:  Khin Thway; Nick Bown; Aisha Miah; Rob Turner; Cyril Fisher
Journal:  Head Neck Pathol       Date:  2014-07-04

7.  Multiple cytokeratin-negative malignant tumors composed only of rhabdoid cells in the renal pelvis: a sarcomatoid urothelial carcinoma?

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

8.  SWI/SNF complex-deficient soft tissue neoplasms: An update.

Authors:  Inga-Marie Schaefer; Jason L Hornick
Journal:  Semin Diagn Pathol       Date:  2020-06-05       Impact factor: 3.464

9.  Extrarenal rhabdoid tumour presenting as a congenital subcutaneous mass.

Authors:  M D Barber; G A Mackinlay; W H Wallace; N M Smith
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

10.  Extrarenal malignant rhabdoid tumors: radiologic findings with histopathologic correlation.

Authors:  Asif Abdullah; Yogesh Patel; Terrence J Lewis; Haitham Elsamaloty; Stephen Strobel
Journal:  Cancer Imaging       Date:  2010-03-18       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.